Cases & Deals

BD Diagnostics establishes patent portfolio for molecular diagnostic sepsis tests

Clients BD Diagnostics

Jones Day represented BD Diagnostics in the establishment of its patent portfolio for molecular diagnostic tests for early prediction of sepsis.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.